Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
PVLA.OQ - Palvella Therapeutics Inc
Palvella Therapeutics Inc to Discuss Topline Results from the Phase 3 SELVA Study
Feb 24, 2026 / 01:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by. Welcome to the Pavela Therapeutics conference call to discuss top-line results from the phase 3 Silver study. At this time, all participants are in listen-only mode. After this previous presentation, there will be a question-and-answer session. To ask a question during the session, you'll need to press 11 on your telephone. You'll then hear automated message I think he is raised.
To withdraw your question, please press 11 again. Please be advised that today's conference is being recorded. I like to hand conference over to the first speaker today, Bahong Wei, Vice President of Corporate Development and new Product Planning. Please go ahead.
Trustpilot
